Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Jin YX et al. | A strategy for enrichment of the bioactive sphingoid base-1-phosphates produced by Hypericum perforatum L. in a balloon type airlift reactor. | 2012 | Bioresour. Technol. | pmid:22940331 |
Yu FX et al. | Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. | 2012 | Cell | pmid:22863277 |
Snider AJ et al. | Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. | 2012 | Prostaglandins Other Lipid Mediat. | pmid:22940715 |
Moon MH et al. | Sphingosine-1-phosphate inhibits interleukin-1β-induced inflammation in human articular chondrocytes. | 2012 | Int. J. Mol. Med. | pmid:22992945 |
Park TS and Goldberg IJ | Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure. | 2012 | Heart Fail Clin | pmid:22999245 |
Ihlefeld K et al. | Evidence for a link between histone deacetylation and Ca²+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. | 2012 | Biochem. J. | pmid:22908849 |
Wang ZY et al. | [Effect of sphingosine 1-phosphate/sphingosine 1-phosphate receptor signal pathway on function of neutrophils]. | 2012 | Zhongguo Shi Yan Xue Ye Xue Za Zhi | pmid:22931670 |
Miller E et al. | Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. | 2012 | Chem. Biol. | pmid:22884261 |
Cannon RE et al. | Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22949658 |
Richerioux N et al. | Rho-ROCK and Rac-PAK signaling pathways have opposing effects on the cell-to-cell spread of Marek's Disease Virus. | 2012 | PLoS ONE | pmid:22952878 |
He S et al. | Self-amplification mechanisms of mast cell activation: a new look in allergy. | 2012 | Curr. Mol. Med. | pmid:22920722 |
Hisano Y et al. | The functional roles of S1P in immunity. | 2012 | J. Biochem. | pmid:22923732 |
Aoyagi T et al. | The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. | 2012 | Lymphat Res Biol | pmid:22984905 |
Chiba K and Yoshii N | [Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis]. | 2012 | Nippon Yakurigaku Zasshi | pmid:22728990 |
Linke B et al. | Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation. | 2012 | Prostaglandins Other Lipid Mediat. | pmid:22732087 |
Yokoyama K et al. | Decrease of serum sphingosine-1-phosphate levels in hemodialysis patients with secondary hyperparathyroidism treated with cinacalcet. | 2012 | Clin. Nephrol. | pmid:22732343 |
Czarnota GJ et al. | Tumor radiation response enhancement by acoustical stimulation of the vasculature. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22778441 |
Upadhyaya P et al. | The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22727907 |
Boussommier-Calleja A et al. | Pharmacologic manipulation of conventional outflow facility in ex vivo mouse eyes. | 2012 | Invest. Ophthalmol. Vis. Sci. | pmid:22807298 |
Kharel Y et al. | Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. | 2012 | Biochem. J. | pmid:22747486 |
Zhang BL et al. | Sphingosine 1-phosphate acts as an activator for the porcine Gpr3 of constitutively active G protein-coupled receptors. | 2012 | J Zhejiang Univ Sci B | pmid:22761247 |
Park SW et al. | Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. | 2012 | J. Am. Soc. Nephrol. | pmid:22095950 |
Kotelevets N et al. | Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis. | 2012 | PLoS ONE | pmid:22761740 |
Nakahara T et al. | Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis via the PI3K/Akt signaling pathway. | 2012 | Fertil. Steril. | pmid:22763095 |
Nijnik A et al. | The role of sphingosine-1-phosphate transporter Spns2 in immune system function. | 2012 | J. Immunol. | pmid:22664872 |
Liu X et al. | Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells. | 2012 | Mol. Cell. Biochem. | pmid:22113622 |
Liu X et al. | ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate. | 2012 | Clin. Chim. Acta | pmid:22115863 |
Juarez JG et al. | Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. | 2012 | Blood | pmid:22049516 |
Pennington LD et al. | Quinolinone-based agonists of S1Pâ‚: use of a N-scan SAR strategy to optimize in vitro and in vivo activity. | 2012 | Bioorg. Med. Chem. Lett. | pmid:22104144 |
Milara J et al. | Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. | 2012 | Thorax | pmid:22106015 |
Raje MR et al. | Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors. | 2012 | Bioorg. Med. Chem. | pmid:22137932 |
Lu H et al. | Senescent endothelial dysfunction is attributed to the up-regulation of sphingosine-1-phosphate receptor-2 in aged rats. | 2012 | Mol. Cell. Biochem. | pmid:22139303 |
Fujii Y et al. | Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities. | 2012 | J. Immunol. | pmid:22131329 |
Ishimaru N et al. | CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy. | 2012 | Am. J. Pathol. | pmid:22067914 |
Krishna SM et al. | Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. | 2012 | Am. J. Pathol. | pmid:22698985 |
Lee SH et al. | Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22679064 |
Ponnusamy S et al. | Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. | 2012 | EMBO Mol Med | pmid:22707406 |
Kunisawa J and Kiyono H | Immunological function of sphingosine 1-phosphate in the intestine. | 2012 | Nutrients | pmid:22666543 |
Yang J et al. | Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling. | 2012 | Circulation | pmid:22668972 |
Li C et al. | Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor. | 2012 | J. Neurophysiol. | pmid:22673325 |
Watson L et al. | Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. | 2012 | J. Clin. Immunol. | pmid:22648459 |
Sato C et al. | Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22659743 |
Tencé M et al. | Increased interaction of connexin43 with zonula occludens-1 during inhibition of gap junctions by G protein-coupled receptor agonists. | 2012 | Cell. Signal. | pmid:21872657 |
Farahat WA et al. | Ensemble analysis of angiogenic growth in three-dimensional microfluidic cell cultures. | 2012 | PLoS ONE | pmid:22662145 |
Somers SJ et al. | Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. | 2012 | Cardiovasc Drugs Ther | pmid:22392184 |
Chakraborty G et al. | Ethanol triggers sphingosine 1-phosphate elevation along with neuroapoptosis in the developing mouse brain. | 2012 | J. Neurochem. | pmid:22393932 |
Schnute ME et al. | Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. | 2012 | Biochem. J. | pmid:22397330 |
Bachmaier K et al. | Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin. | 2012 | PLoS ONE | pmid:22355325 |
Lucki NC and Sewer MB | Nuclear sphingolipid metabolism. | 2012 | Annu. Rev. Physiol. | pmid:21888508 |
Duru EA et al. | SRC regulates sphingosine-1-phosphate mediated smooth muscle cell migration. | 2012 | J. Surg. Res. | pmid:21920544 |
Belvitch P and Dudek SM | Role of FAK in S1P-regulated endothelial permeability. | 2012 | Microvasc. Res. | pmid:21925517 |
Liu Q et al. | Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. | 2012 | PLoS ONE | pmid:22848628 |
Asghar MY et al. | Sphingosine 1-phosphate and human ether-a'-go-go-related gene potassium channels modulate migration in human anaplastic thyroid cancer cells. | 2012 | Endocr. Relat. Cancer | pmid:22889737 |
Kim BJ et al. | Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22879631 |
Knapp M et al. | Myocardial infarction changes sphingolipid metabolism in the uninfarcted ventricular wall of the rat. | 2012 | Lipids | pmid:22833182 |
Brizuela L et al. | First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. | 2012 | Mol. Cancer Ther. | pmid:22784711 |
Japtok L et al. | Sphingosine 1-phosphate modulates antigen capture by murine Langerhans cells via the S1P2 receptor subtype. | 2012 | PLoS ONE | pmid:23145172 |
Zhang L et al. | A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. | 2012 | J. Exp. Med. | pmid:23148237 |
Qiao Y et al. | Sphingosine 1-phosphate elicits proinflammatory responses in ARPE-19 cells. | 2012 | Invest. Ophthalmol. Vis. Sci. | pmid:23150617 |
Mendoza A et al. | The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. | 2012 | Cell Rep | pmid:23103166 |
Kurek K et al. | [Role of sphingolipids in digestive system]. | 2012 | Postepy Hig Med Dosw (Online) | pmid:23175343 |
Wilkerson BA et al. | Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. | 2012 | J. Biol. Chem. | pmid:23135269 |
Tar L and Vécsei L | [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism]. | 2012 | Ideggyogy Sz | pmid:23136726 |
Spohr TC et al. | Sphingosine 1-phosphate-primed astrocytes enhance differentiation of neuronal progenitor cells. | 2012 | J. Neurosci. Res. | pmid:22588662 |
Parrill AL et al. | Structure of the first sphingosine 1-phosphate receptor. | 2012 | Sci Signal | pmid:22623751 |
Trifilieff A and Fozard JR | Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. | 2012 | J. Pharmacol. Exp. Ther. | pmid:22570366 |
Van Brocklyn JR and Williams JB | The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. | 2012 | Comp. Biochem. Physiol. B, Biochem. Mol. Biol. | pmid:22613819 |
Loh KC et al. | Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. | 2012 | PLoS ONE | pmid:22606352 |
Okada T and Nakamura S | [Role of S1P acting both inside and outside the cells]. | 2012 | Seikagaku | pmid:22550899 |
Brizuela L and Cuvillier O | Biochemical methods for quantifying sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphate. | 2012 | Methods Mol. Biol. | pmid:22528435 |
Pitman MR et al. | Isoform-selective assays for sphingosine kinase activity. | 2012 | Methods Mol. Biol. | pmid:22528436 |
Bode C and Gräler MH | Quantification of sphingosine-1-phosphate and related sphingolipids by liquid chromatography coupled to tandem mass spectrometry. | 2012 | Methods Mol. Biol. | pmid:22528437 |
Morishige J et al. | A cleanup method for mass spectrometry of sphingosine-1-phosphate in blood and solid tissues using a phosphate capture molecule. | 2012 | Methods Mol. Biol. | pmid:22528438 |
Visentin B et al. | Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples. | 2012 | Methods Mol. Biol. | pmid:22528439 |
Obinata H and Hla T | Assessment of sphingosine-1-phosphate activity in biological samples by receptor internalization and adherens junction formation. | 2012 | Methods Mol. Biol. | pmid:22528440 |
Medlin MD et al. | Quantifying sphingosine-1-phosphate-dependent activation of the RhoGTPases. | 2012 | Methods Mol. Biol. | pmid:22528442 |
Belmonte SA and Suhaiman L | Optimized protocols to analyze sphingosine-1-phosphate signal transduction pathways during acrosomal exocytosis in human sperm. | 2012 | Methods Mol. Biol. | pmid:22528443 |
Knapp M et al. | Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. | 2012 | Basic Res. Cardiol. | pmid:22961594 |
Shea BS and Tager AM | Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. | 2012 | Proc Am Thorac Soc | pmid:22802282 |
Morel S et al. | The natural cardioprotective particle HDL modulates connexin43 gap junction channels. | 2012 | Cardiovasc. Res. | pmid:21960685 |
Su G et al. | Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. | 2012 | Am. J. Respir. Crit. Care Med. | pmid:21980034 |
Nakahara K et al. | The Sjögren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. | 2012 | Mol. Cell | pmid:22633490 |
Castillo-Badillo JA et al. | Sphingosine 1-phosphate-mediated α1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions. | 2012 | Biochim. Biophys. Acta | pmid:22019450 |
Christopherson KW | PBSCs Sphingoling along S1P/S1P1 axis. | 2012 | Blood | pmid:22262738 |
Fujii Y et al. | Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P. | 2012 | Biochim. Biophys. Acta | pmid:22265714 |
Dakroub Z and Kreydiyyeh SI | Sphingosine-1-phosphate is a mediator of TNF-α action on the Na+/K+ ATPase in HepG2 cells. | 2012 | J. Cell. Biochem. | pmid:22271589 |
Santulli P et al. | Sphingosine pathway deregulation in endometriotic tissues. | 2012 | Fertil. Steril. | pmid:22277765 |
Tse KW et al. | Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells. | 2012 Jan-Feb | Cell. Immunol. | pmid:22507871 |
Fournie P et al. | Sphingosine-1 phosphate prevents ethanol-induced corneal epithelial apoptosis. | 2012 Mar-Apr | Indian J Ophthalmol | pmid:22446906 |
Iwaki S et al. | Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells. | 2012 Nov-Dec | Biochim. Biophys. Acta | pmid:22819712 |
Takuwa Y et al. | Sphingosine-1-phosphate signaling in physiology and diseases. | 2012 Sep-Oct | Biofactors | pmid:22674845 |
Cortez-Retamozo V et al. | Angiotensin II drives the production of tumor-promoting macrophages. | 2013 | Immunity | pmid:23333075 |
Takuwa Y et al. | Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. | 2013 | Biochim. Biophys. Acta | pmid:22735357 |
Kunkel GT et al. | Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. | 2013 | Nat Rev Drug Discov | pmid:23954895 |
Moriue T et al. | Sphingosine 1-phosphate attenuates peroxide-induced apoptosis in HaCaT cells cultured in vitro. | 2013 | Clin. Exp. Dermatol. | pmid:23837937 |
Kager LM et al. | Endogenous protein C has a protective role during Gram-negative pneumosepsis (melioidosis). | 2013 | J. Thromb. Haemost. | pmid:23216621 |
Liang J et al. | Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | 2013 | Cancer Cell | pmid:23273921 |
Cartwright TA et al. | Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers. | 2013 | J. Cereb. Blood Flow Metab. | pmid:23168528 |
Willis MA and Cohen JA | Fingolimod therapy for multiple sclerosis. | 2013 | Semin Neurol | pmid:23709211 |
Tatematsu S et al. | Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. | 2013 | Arterioscler. Thromb. Vasc. Biol. | pmid:23723371 |